Clinical trials
Terminated Carcinoma, Hepatocellular trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 46 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 3 |
| University of California, San Francisco | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
| Albert Einstein College of Medicine | 1 |
| Centre Georges Francois Leclerc | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Centre Oscar Lambret | 1 |
| Duke University | 1 |
| Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 46 |
| Liver Neoplasms | 10 |
| Cholangiocarcinoma | 2 |
| Colorectal Neoplasms | 2 |
| Fibrosis | 2 |
| Gastrointestinal Stromal Tumors | 2 |
| Pancreatic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Acute Kidney Injury | 1 |
| Appendiceal Neoplasms | 1 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.